Sandbox Cardiovascular Drugs2/Vasodilators: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
No edit summary
 
(2 intermediate revisions by the same user not shown)
Line 1: Line 1:
{|class="infobox" style="position: fixed; top: 210px; right: 20px; margin: 0 0 0 0; border: 0; float: right; width: 17.5%; background: #104E8B; border-radius: 10px 10px 10px 10px;" cellpadding="0" cellspacing="0";
{|class="infobox" style="position: fixed; top: 210px; right: 20px; margin: 0 0 0 0; border: 0; float: right; width: 25%; background: #104E8B; border-radius: 10px 10px 10px 10px;"
|-
|-
! style="font-size: 99%; padding: 0 5px; background: #104E8B;" | [[Sandbox Cardiovascular Drugs2|{{Fontcolor|#F8F8FF|Cardiovascular Drugs}}]]
| style="font-weight: bold; font-size: 125%; padding: 5px 5px; text-align: center; background: #104E8B; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5);" | [[Sandbox Cardiovascular Drugs2|{{Fontcolor|#F8F8FF|Cardiovascular Drugs}}]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #4479BA; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5);" align=left |[[Sandbox Cardiovascular Drugs2/Antiarrhythmics|{{Fontcolor|#F8F8FF|Antiarrhythmics}}]]
| style="font-weight: bold; font-size: 100%; padding: 5px 5px; background: #4479BA; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5);" align=left |[[Sandbox Cardiovascular Drugs2/Antiarrhythmics|{{Fontcolor|#F8F8FF|Antiarrhythmics}}]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #4479BA; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5);" align=left |[[Sandbox Cardiovascular Drugs2/Antihypertensives|{{Fontcolor|#F8F8FF|Antihypertensives}}]]
| style="font-weight: bold; font-size: 100%; padding: 5px 5px; background: #4479BA; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5);" align=left |[[Sandbox Cardiovascular Drugs2/Antihypertensives|{{Fontcolor|#F8F8FF|Antihypertensives}}]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #4479BA; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5);" align=left |[[Sandbox Cardiovascular Drugs2/Antithrombotics|{{Fontcolor|#F8F8FF|Antithrombotics}}]]
| style="font-weight: bold; font-size: 100%; padding: 5px 5px; background: #4479BA; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5);" align=left |[[Sandbox Cardiovascular Drugs2/Antithrombotics|{{Fontcolor|#F8F8FF|Antithrombotics}}]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #4479BA; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5);" align=left |[[Sandbox Cardiovascular Drugs2/Beta Blockers|{{Fontcolor|#F8F8FF|Beta Blockers}}]]
| style="font-weight: bold; font-size: 100%; padding: 5px 5px; background: #4479BA; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5);" align=left |[[Sandbox Cardiovascular Drugs2/Beta Blockers|{{Fontcolor|#F8F8FF|Beta Blockers}}]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #4479BA; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5);" align=left |[[Sandbox Cardiovascular Drugs2/Calcium Channel Blockers|{{Fontcolor|#F8F8FF|Calcium Channel Blockers}}]]
| style="font-weight: bold; font-size: 100%; padding: 5px 5px; background: #4479BA; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5);" align=left |[[Sandbox Cardiovascular Drugs2/Calcium Channel Blockers|{{Fontcolor|#F8F8FF|Calcium Channel Blockers}}]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #4479BA; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5);" align=left |[[Sandbox Cardiovascular Drugs2/Cardiac Stimulants|{{Fontcolor|#F8F8FF|Cardiac Stimulants}}]]
| style="font-weight: bold; font-size: 100%; padding: 5px 5px; background: #4479BA; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5);" align=left |[[Sandbox Cardiovascular Drugs2/Cardiac Stimulants|{{Fontcolor|#F8F8FF|Cardiac Stimulants}}]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #4479BA; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5);" align=left |[[Sandbox Cardiovascular Drugs2/Diuretics|{{Fontcolor|#F8F8FF|Diuretics}}]]
| style="font-weight: bold; font-size: 100%; padding: 5px 5px; background: #4479BA; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5);" align=left |[[Sandbox Cardiovascular Drugs2/Diuretics|{{Fontcolor|#F8F8FF|Diuretics}}]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #4479BA; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5);" align=left |[[Sandbox Cardiovascular Drugs2/Lipid-Modifying Agents|{{Fontcolor|#F8F8FF|Lipid-Modifying Agents}}]]
| style="font-weight: bold; font-size: 100%; padding: 5px 5px; background: #4479BA; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5);" align=left |[[Sandbox Cardiovascular Drugs2/Lipid-Modifying Agents|{{Fontcolor|#F8F8FF|Lipid-Modifying Agents}}]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #4479BA; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5);" align=left |[[Sandbox Cardiovascular Drugs2/Renin-Angiotensin System Inhibitors|{{Fontcolor|#F8F8FF|Renin-Angiotensin System Inhibitors}}]]
| style="font-weight: bold; font-size: 100%; padding: 5px 5px; background: #4479BA; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: 0 1px 1px rgba(0, 0, 0, 0.5);" align=left |[[Sandbox Cardiovascular Drugs2/Renin-Angiotensin System Inhibitors|{{Fontcolor|#F8F8FF|Renin-Angiotensin System Inhibitors}}]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #4479BA; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: inset 0 0 10px #F0F8FF;" align=left |[[Sandbox Cardiovascular Drugs2/Vasodilators|{{Fontcolor|#F8F8FF|Vasodilators}}]]
! style="margin: 50px 50px; font-size: 100%; padding: 5px 5px; background: #4479BA; border-radius: 5px 5px 5px 5px; text-shadow: 0 -1px 0 rgba(0, 0, 0, 0.5); box-shadow: inset 0 0 10px #F0F8FF;" align=left |[[Sandbox Cardiovascular Drugs2/Vasodilators|{{Fontcolor|#F8F8FF|Vasodilators}}]]
|}
|}
<div style="width: 75%;">
</div>

Latest revision as of 22:10, 30 July 2014

Cardiovascular Drugs
Antiarrhythmics
Antihypertensives
Antithrombotics
Beta Blockers
Calcium Channel Blockers
Cardiac Stimulants
Diuretics
Lipid-Modifying Agents
Renin-Angiotensin System Inhibitors
Vasodilators












Retrieved from "https://www.wikidoc.org/index.php?title=Sandbox_Cardiovascular_Drugs2/Vasodilators&oldid=1005234"